Peer Mentorship's Paradox in Dialysis

We commend Golestaneh et al.1 for their pragmatic randomized controlled trial the PEER-HD trial, investigating the effect of peer mentorship on hospitalizations and emergency department (ED) visits among high-risk hemodialysis patients, published in JASN. This innovative study addresses a critical gap in patient-centered care for individuals with kidney failure, a vulnerable population burdened by frequent hospitalizations, and provides valuable insights into the challenges and potential benefits of peer-led interventions. Although the trial's primary intention-to-treat analysis showed no significant reduction in composite hospitalization or ED visits, the as-treated analysis and subgroup findings offer valuable insights for future interventions. First, the trial's design rigorously accounts for real-world variability by including diverse patient populations across two geographic sites. However, the marked differences in outcomes between Bronx, New York, and Nashville, Tennessee, suggest that contextual factors—such as local health care practices, socioeconomic disparities, or pandemic-related disruptions—may significantly influence intervention effectiveness. Although the authors adjusted for site-level clustering, future studies could enhance robustness by prospectively evaluating site-specific barriers such as access to primary care, considering social support networks, and incorporating mixed-methods analyses to disentangle these complex interactions. Second, the prespecified “as-treated” analysis (defining adherence as >20 minutes of mentor-mentee contact) demonstrated a striking 40% reduction in hospitalizations/ED visits. This underscores the potential dose-dependent nature of peer support. Yet, the threshold of 20 minutes lacks empirical justification and may overlook qualitative aspects of engagement such as rapport and content relevance. We recommend future trials employ tiered adherence criteria, such as low/medium/high contact, and integrate qualitative assessments of mentorship quality to better define the “active ingredients” of successful peer interactions. Third, the exploratory subgroup findings—particularly the benefit among Black participants—are intriguing and align with evidence suggesting that marginalized populations may derive greater value from culturally concordant support.2 However, these analyses risk type 1 error because of multiplicity. Independent replication in larger cohorts, coupled with mechanistic studies, such as assessing trust in health care systems or self-efficacy mediators, is needed to validate these observations and inform equitable implementation. Finally, although the intervention improved dialysis-specific knowledge, as reflected by the Chronic Hemodialysis Knowledge Survey (CHeKS)-PLUS scores, it did not lead to measurable changes in self-management behaviors, such as interdialytic weight gain. This dissociation suggests that knowledge alone may be insufficient to alter clinical outcomes without concurrent structural support such as access to transportation and flexible dialysis schedules. Future interventions could hybridize peer mentorship with systemic changes, such as community health worker integration to address multifactorial barriers to care. In conclusion, the PEER-HD trial highlights both the promise and complexity of peer mentorship in hemodialysis care. Although the primary intention-to-treat results were neutral, the signals of efficacy in adherent participants and specific subgroups warrant further exploration. We echo the authors' call for optimized mentorship models and stress the importance of embedding such interventions within broader, patient-centered care frameworks.